Why the CSL Limited share price hit a record high this week

CSL Limited (ASX: CSL): Buy, hold, sell?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is CSL Limited (ASX: CSL) the best blue-chip share to buy on the local market? From memory I've made it my top monthly stock to buy twice over the past year and not for nothing either. 

This morning the healthcare giant printed a new record high of $244.99 despite it releasing no material news to the market.

However, CSL has recently enjoyed a number of broker upgrades to its valuation as I covered in this article two days ago.

According to financial news wires Goldman Sachs, Morgan Stanley and Credit Suisse have all lifted their valuations thanks mainly to data suggesting CSL is experiencing strong demand for its core immunoglobulin (IG) products used to treat patients with blood problems. 

Local investors are also being drawn into the stock as the Australian dollar falls with an outlook for more weakness on the back of more rate cuts or potentially unorthodox monetary policy. CSL reports and earns the majority of its profits in US dollars and local investors are direct beneficiaries of a weaker AUD/USD spot rate.

It's possible a new bullish broker valuation today is lifting the stock.

As I noted earlier in the week 'broker valuations' on these type of growth businesses commonly use a "sum of the parts" methodology where the present value of future cash flows is directly dependent on the discount rate used.

As global interest rates fall discount rates are being lowered to boost the 'sum of the parts' valuations.

CSL itself it guiding for another year of double-digit profit growth and this kind of return is likely to prove more attractive given falling risk-free and risk-on rates globally. 

As stated before I wouldn't be averse to buying CSL shares even at today's elevated levels. Others in the healthcare space worth a look include Sonic Healthcare Limited (ASX: SHL) and the richly valued Pro Medicus Limited (ASX: PME). 

Tom Richardson owns shares of CSL Ltd. and Pro Medicus Ltd.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »

Three businesspeople leap high with the CBD in the background.
Share Market News

Boom! ASX 200 blasts to new record highs

ASX 200 investors just sent the benchmark index into uncharted territory.

Read more »